<p>This thesis focuses on the identification of genetic factors underlying two inherited human phenotypes: hearing loss and monoamine oxidase activity. </p><p>Non-syndromic hearing loss segregating in a Swedish family was tested for linkage to 13 previously reported candidate loci for hearing disabilities. Linkage was found to two loci: DFNA12 (llq22-q24) and DFNA2 (lp32). A detailed analysis of the phenotypes and haplotypes shared by the affected individuals supported the hypothesis of digenic inheritance of hearing disability in the Swedish family. Mutation screening of α-tectorin, a gene residing within the DFNA12 region revealed a mutation of a conserved amino acid (Cys to Ser), that segregated with the disease. The identification of the mutation added support to the involvement of α-tectorin in hearing disabilities. In contrast, no mutations were identified in two candidate genes at the DFNA2 locus, that were reported to cause hearing loss in other families. It is possible that the DFNA2 locus contains a third, not yet identified, hearing loss gene. </p><p>Monoamine oxidase A (MAOA) and B (MAOB) catalyze the degradation of certain neurotransmitters in the central nervous system and are associated with specific behavioral and neuropsychiatric human traits. Activity levels of both monoamine oxidases (MAO) are highly variable among humans and are determined by unknown genetic factors. This study investigated the relationship of different MAO alleles with MAO mRNA levels and enzyme activity in human brain. Several novel DNA polymorphisms were identified in a group of Swedish individuals. Haplotypes containing several closely located MAOA polymorphisms were assessed in Asian, African, and Caucasian populations. The haplotype distribution and diversity pattern found among the three populations supported the occurrence of a bottleneck during the dispersion of modem humans from Africa. </p><p>Allelic association studies conducted on postmortem human brain samples, revealed the association between a SNP in the MAOB intron 13, and different levels of both MAO enzyme activities. This suggested that this SNP is in linkage disequilibrium with at least one novel functional DNA polymorphism that controls MAO enzyme activities in human brain. The identification of functional polymorphisms regulating the activity of these enzymes will help to elucidate the involvement of MAO in human behavior and neuropsychiatric conditions. </p>

<p>Important candidate genes to human bone phenotypes are those involved in the regulation of hormonal action, such as the vitamin D receptor (VDR) and the estrogen receptor-α (ERα) genes and their cofactors. RIZ1 is a specific ERα cofactor proved to strongly enhance the function of the ERα. </p><p>The main focus of this thesis has been to study genetic variants in the VDR and RIZ genes and their associations to human bone phenotypes using candidate gene and functional approaches. Specifically, polymorphisms in the VDR 3’ untranslated region (UTR) and a deletion/insertion polymorphism of a proline in the RIZ gene were investigated.</p><p>The candidate gene approach was applied to large-scale population-based cohorts of pre-and post-menopausal women from Sweden and of elderly men from Sweden and Hong Kong. VDR 3’ UTR polymorphisms were associated with peak bone mass and body composition in young women. Further analysis of common VDR 3’ UTR haplotypes confirmed the association with BMD and risk of fractures in elderly men from Sweden and Hong Kong. The VDR polymorphisms were investigated for cis-acting effects, affecting allelic expression in the normal chromosomal context of human bone cells. The VDR allelic transcripts in the bone samples were unequally expressed, suggesting presence of regulatory variants in the 3’ UTR. </p><p>The polymorphism in the RIZ gene was strongly associated to BMD in pre- and postmenopausal women and in elderly men. The functional analyses included reporter constructs containing the RIZ polymorphic variants transfected in a cell line and its abilities in coactivating the ERα were examined. The variants were functionally different in coactivating the ERα-receptor complex. </p><p>To summarize, the results of this thesis show novel evidence for functional relevant polymorphisms in candidate genes to human bone phenotypes. These polymorphisms may contribute to the variation seen in BMD and risk of fractures in the population.</p>

Genetic mapping contributes to the understanding of functional mechanisms that underlie the constitution of living organisms and their physiology. For example, genetic mapping can be used in conceiving new treatments of congenital or infectious diseases and in selecting plants and animals that have a higher and better production. The most common approaches of genetic mapping exploit the allelic segregation in a pedigree during only a few number of generations and, consequently, they do not have a sufficient resolution to allow an effective gene isolation and cloning. An alternative to these approaches is to study allelic associations along the history of a population. This requires accurate models of population demography, genetic inheritance and allelic associations. This thesis contributes to the modelling of allelic associations (linkage disequilibrium, LD) and to the assessment of the effects of selection and inbreeding. In a simulation framework, we fitted the multimarker-multiallelic LD with an exponential function characterised by two parameters: the distance (R) at which LD is independent of the genetic distance and the LD reached at this distance (residual LD, rs). As an application of this approach, the LD was estimated in five populations of pigs. We observed a long range LD (>10cM) that was explained by the random drift. Moreover, significantly increased LD was found in regions harbouring selected QTL (quantitative trait loci), suggesting an effect of selection. Fitting LD with the exponential model proposed in simulations indicated that mapping methods using LD (LDM) can achieve a resolution of ~3cM in the populations of pigs we have studied and can be powerful with a marker spacing of 5-10cM. As illustrated with these data from pigs, the model that we used to fit LD offers opportunities to characterise allelic association in populations, estimate the required marker density for genome-wide LD studies and determine the expected resolution of LDM. It is also shown that the proposed model can help overcoming the assumptions of asymptotic linkage equilibrium and independence between markers that are commonly made in LDM but are not always fulfilled.

This thesis focuses on the identification of genetic factors underlying two inherited human phenotypes: hearing loss and monoamine oxidase activity. Non-syndromic hearing loss segregating in a Swedish family was tested for linkage to 13 previously reported candidate loci for hearing disabilities. Linkage was found to two loci: DFNA12 (llq22-q24) and DFNA2 (lp32). A detailed analysis of the phenotypes and haplotypes shared by the affected individuals supported the hypothesis of digenic inheritance of hearing disability in the Swedish family. Mutation screening of α-tectorin, a gene residing within the DFNA12 region revealed a mutation of a conserved amino acid (Cys to Ser), that segregated with the disease. The identification of the mutation added support to the involvement of α-tectorin in hearing disabilities. In contrast, no mutations were identified in two candidate genes at the DFNA2 locus, that were reported to cause hearing loss in other families. It is possible that the DFNA2 locus contains a third, not yet identified, hearing loss gene. Monoamine oxidase A (MAOA) and B (MAOB) catalyze the degradation of certain neurotransmitters in the central nervous system and are associated with specific behavioral and neuropsychiatric human traits. Activity levels of both monoamine oxidases (MAO) are highly variable among humans and are determined by unknown genetic factors. This study investigated the relationship of different MAO alleles with MAO mRNA levels and enzyme activity in human brain. Several novel DNA polymorphisms were identified in a group of Swedish individuals. Haplotypes containing several closely located MAOA polymorphisms were assessed in Asian, African, and Caucasian populations. The haplotype distribution and diversity pattern found among the three populations supported the occurrence of a bottleneck during the dispersion of modem humans from Africa. Allelic association studies conducted on postmortem human brain samples, revealed the association between a SNP in the MAOB intron 13, and different levels of both MAO enzyme activities. This suggested that this SNP is in linkage disequilibrium with at least one novel functional DNA polymorphism that controls MAO enzyme activities in human brain. The identification of functional polymorphisms regulating the activity of these enzymes will help to elucidate the involvement of MAO in human behavior and neuropsychiatric conditions.

Important candidate genes to human bone phenotypes are those involved in the regulation of hormonal action, such as the vitamin D receptor (VDR) and the estrogen receptor-α (ERα) genes and their cofactors. RIZ1 is a specific ERα cofactor proved to strongly enhance the function of the ERα. The main focus of this thesis has been to study genetic variants in the VDR and RIZ genes and their associations to human bone phenotypes using candidate gene and functional approaches. Specifically, polymorphisms in the VDR 3’ untranslated region (UTR) and a deletion/insertion polymorphism of a proline in the RIZ gene were investigated. The candidate gene approach was applied to large-scale population-based cohorts of pre-and post-menopausal women from Sweden and of elderly men from Sweden and Hong Kong. VDR 3’ UTR polymorphisms were associated with peak bone mass and body composition in young women. Further analysis of common VDR 3’ UTR haplotypes confirmed the association with BMD and risk of fractures in elderly men from Sweden and Hong Kong. The VDR polymorphisms were investigated for cis-acting effects, affecting allelic expression in the normal chromosomal context of human bone cells. The VDR allelic transcripts in the bone samples were unequally expressed, suggesting presence of regulatory variants in the 3’ UTR. The polymorphism in the RIZ gene was strongly associated to BMD in pre- and postmenopausal women and in elderly men. The functional analyses included reporter constructs containing the RIZ polymorphic variants transfected in a cell line and its abilities in coactivating the ERα were examined. The variants were functionally different in coactivating the ERα-receptor complex. To summarize, the results of this thesis show novel evidence for functional relevant polymorphisms in candidate genes to human bone phenotypes. These polymorphisms may contribute to the variation seen in BMD and risk of fractures in the population.

Apomixis, or asexual seed development, if introduced into crop species, has the potential to greatly improve global food production. Towards this goal, this study focused on uncovering the genetic mechanisms that control the parthenogenesis step within apomixis whereby fertilisation is avoided. In the model apomict, Hieracium praealtum (Asteraceae), parthenogenesis is controlled by the LOSS OF PARTHENOGENESIS (LOP) locus. Previous research showed that in addition to genomic copies of candidate genes at LOP, the genome has at least three other copies referred to as alternative alleles. The main goal of this study was to investigate four candidate genes, Genes B, X, H and Y, at LOP by generating segregation data of the alternative alleles. BAC clones containing alternative allele sequences were identified and Roche 454 pyrosequenced. These sequences were used to design alternative allele specific primers for genotyping two Hieracium praealtum polyhaploid populations (~ 300 plants). Four major conclusions were drawn from this study. First, the alternative alleles were in fact acting like alleles to the LOP alleles of Genes B, X and Y. Second, allelic sequence divergence (ASD) of the LOP alleles of Genes B and X relative to the alternative alleles, indicated a recent and separate evolutionary history. Third and, unexpectedly, recombination was detected at the LOP locus, in contrast to other apomixis loci reported in the literature. Furthermore, Gene B was found to be very closely associated with parthenogenesis in the polyhaploid population indicating that it may be essential to parthenogenesis and therefore requires further investigation. On the other hand, the absence of Genes X, Y and H, due to recombination, had no impact upon parthenogenesis. Fourth, the sequence data suggested that the LOP and alternative alleles originated from a shared common allele ancestor. It is hoped that these findings have made a significant contribution towards the future goal of introducing apomixis into crop species.

Recent Genome Wide Association Studies (GWAS) have identified a series of single nucleotide polymorphism (SNP)s that are associated with Alzheimer’s disease (AD). One of the SNPs, rs3851179 (G/A), is near the gene phosphatidylinositol-binding clathrin assembly protein (PICALM). To evaluate whether this SNP is associated with PICALM expression, we quantified PICALM mRNA in 56 brain cDNA samples. Using linear regression analysis, we analyzed PICALM expression relative to rs3851179, AD status, and cell type specific markers. An association was detected between rs3851179 and PICALM, microvessel mRNA, glial fibrillary acidic protein (GFAP) mRNA, and synaptophysin (SYN) mRNA. To gain clarity into other possible SNP mechanisms, we searched brain cDNA for PICALM splice variants. We identified several PICALM splice variants involving exons 13-19. To identify and gain an estimation of relative abundance of splice variants, we PCR-amplified across exons 13-20 in cDNA from six individuals, three rs3851179 GG individuals and three rs3851179 AA individuals. Sequencing the cloned isoforms we found that PICALM lacking exon 13 (delta 13) is the most abundant isoform. Other isoforms detected included deletion of exon 18-19. We targeted the latter part of the gene, exon 17-20, to investigate unequal allelic expression using next generation sequencing. Individuals heterozygous for rs76719109 (n= 35), located in exon 17, were used to study the abundance of G/T allele in cDNA and genomic DNA. When we analyzed the T:G allelic ratio, the variant lacking exons 18 and 19 showed unequal allelic expression (p-value < 0.001) in a subset of individuals. One individual was an outlier, showing overall unequal allelic expression, which maybe be harboring a rare mutation capable of modifying PICALM expression. The PICALM intronic SNP rs588076 was associated with delta 18-19 isoform splicing (p-value < 0.001). In conclusion, this study gained a greater insight into the role of AD genetics in PICALM expression and splicing.

Le chien présente de nombreuses maladies génétiques dont les rétinopathies auxquelles je me suis intéressée. Historiquement, l’homme a appliqué aux chiens une sélection artificielle extrêmement forte, créant ainsi près de 400 races répondant à des besoins spécifiques. En uniformisant ainsi de nombreux traits phénotypiques et comportementaux, l’homme a sélectionné les allèles recherchés mais a également concentré involontairement des allèles délétères responsables de maladies génétiques. Ces maladies étant pour beaucoup cliniquement et génétiquement similaires aux maladies humaines, le chien constitue alors un modèle de choix pour en rechercher les bases génétiques et développer de nouvelles thérapies pour un bénéfice mutuel pour l’homme et le chien. J’ai travaillé sur l’Atrophie Progressive de la Rétine (APR) dans deux races avec le concours du Dr Gilles Chaudieu et des clubs de race : le border collie et le berger picard. Concernant l’APR du border collie, les analyses réalisées avant mon arrivée avaient identifié un locus de 20Mb sur le chromosome X. J’ai tout d’abord mis à jour les données épidémiologiques et cliniques d’environ 500 chiens et poursuivi la collecte de prélèvements. Une analyse de liaison génétique pangénomique sur 130 chiens m’a permis de confirmer le mode de transmission et le locus. J’ai ensuite conduis plusieurs analyses génétiques (« homozygosity mapping », analyses des génotypes, séquençage de gènes candidats) sans pour autant réduire le locus ni identifier de mutation causale. Dans ce contexte et grâce à l’avènement des nouvelles technologies de séquençage, j’ai choisi de séquencer le génome complet de trois chiens atteints et deux porteurs apparentés. Ce travail m’a permis d’identifier 117variants dont 9 dans le locus d’intérêt, mais aucun dans des régions codantes. Je me suis donc focalisée sur les variants de régions régulatrices pour 13 gènes candidats. De plus, j’ai identifié cinq variants structuraux, encore en cours d’étude. Concernant l’APR du berger picard, nous avons relancé le projet par la collecte de prélèvements et la réalisation d’un pedigree de 154 chiens. Ce travail a amené à une collaboration tripartite internationale par le séquençage de deux chiens atteints et deux indemnes d’APR, dont les analyses sont en cours. Cette thèse m’a permis d’aborder la génétique d’une maladie génétique rare chez l’homme grâce à un modèle spontané original ; et même si ce travail n’a pas abouti à l’identification de mutations à ce jour, ces APR restent de bons modèles génétique et thérapeutique pour les rétinites pigmentaires humaines. / Dogs are affected by numerous genetic diseases including retinopathies, the subject of my thesis. Historically, humans have exerted a very strong artificial selection to dogs, thus creating some 400 breeds to perform specific tasks or to harbour specific traits. By such an homogenisation of phenotypic and behavioural traits, humans have selected desired alleles but also concentrated undesired deleterious alleles responsible of genetic diseases. These diseases are clinically and genetically similar to human genetic diseases, making dogs a model of choice to search for the genetic bases of such genetic diseases and to develop new therapies for a mutual benefit for dogs and humans. I worked on Progressive Retinal Atrophies (PRA) in two breeds, thanks to the contribution of the veterinary ophthalmologist Dr. Gilles Chaudieu and the breed clubs of border collies and berger picard. Concerning the border collie PRA, genetic analyses performed before my thesis allowed the identification of a locus of 20Mb on the X chromosome. I first completed and supplemented the epidemiological and clinical data for about 500 dogs and continued the sample and data collection. A first genetic linkage analysis on 130 dogs allowed to confirm the transmission mode and the locus. I then performed several genetic analyses (« homozigosity mapping », genotypes analyses, candidate gene sequencing) without significantly reducing the locus,neither finding the causal mutation, unfortunately. In this context and thanks to the development of new sequencing technologies, I chose to sequence the entire genome of three PRA affected border collies and two unaffected related dogs. This work allowed the identification of 117variants, 9 in the locus but none in coding regions. I thus focused my research on genetic variants from potential regulatory regions for 13 candidate genes. In addition, I identified five structural variants. The analysis of these variants is still ongoing. Concerning the berger picard PRA, we have re-initiated the project by collecting samples and designing a large pedigree of 154 dogs. This workled to an international collaboration by the sequencing of the entire genomes of 2 affected and 2 unaffected bergers picards for which the statistical analyses are ongoing. This thesis allowed me to work on the genetics of rare diseases in humans with a spontaneous and original animal model and even if thiswork has not yet reached the identification of the mutations, these two PRAs in these two breeds remain good genetic and therapeutic models for human RP RetinitisPigmentosa.

Estudos recentes demonstraram que a variação de expressão alelo-específica é mais comum do que se imaginou, podendo chegar, em humanos, a 50% dos genes. Identificar os genes submetidos ao controle de expressão alelo-específica é muito importante para o entendimento de várias doenças, incluindo o câncer. A identificação dos alvos desse tipo de regulação diferencial é difícil, principalmente devido à dificuldade de se avaliar a expressão de cada alelo individualmente. Neste trabalho, abordamos este problema com uma estratégia de análise in-silico, fundamentada na integração de dados públicos do genoma humano, dados de expressão (como cDNAs, SAGE e MPSS) e dados sobre polimorfismos (SNPs). Desenvolvemos um banco de dados de polimorfismos de base única (Single-Nucleotide Polymorphism - SNPs) associados a etiquetas alternativas de SAGE (Serial Analysis of Gene Expression) e MPSS (massively parallel signature sequencing). SAGE e MPSS são técnicas desenvolvidas para análise da expressão de genes em larga escala. Ambas as técnicas têm como princípio a produção de pequenas seqüências marcadoras (etiquetas), adjacentes aos sítios de enzimas de restrição que estiverem mais próximo da cauda poli-A do RNA mensageiro. Tais etiquetas são seqüenciadas em grande escala e a quantidade de etiquetas é usada para medir a abundância relativa dos RNAs mensageiros correspondentes. A presença de SNPs nos sítios de restrição ou nas seqüências das etiquetas pode gerar etiquetas distintas para alelos do mesmo gene, que denominamos etiquetas alternativas. Neste trabalho, empregamos o banco de dados de etiquetas alternativas associadas a SNPs para identificar genes com expressão alélica diferencial. Usando esta estratégia, identificamos 812 genes com expressão monoalélica, Estudos anteriores comprovaram que, dentre os 812 genes identificados, cinco estão sujeitos ao fenômeno de imprinting genômico. Durante o decorrer deste estudo, trabalhos realizados por outros grupos apontaram outros 73 genes do nosso repertório como genes que apresentam variação no nível de expressão dos alelos em heterozigotos. Com objetivo de confirmar a expressão alélica diferencial dos nossos candidatos, selecionamos 29 genes para validação experimental. Para 12 destes genes não achamos indivíduos heterozigotos, impossibilitando a análise da expressão dos alelos. Dentre os outros 17 genes, três apresentaram expressão bialélica e 14 apresentaram expressão alélica diferencial nos indivíduos heterozigotos, sendo que 3 deles apresentaram expressão monoalélica. Estes resultados sugerem que nossa estratégia pode contribuir significativamente na identificação de genes com expressão alélica diferencial. / Recent studies have shown that variation of allelic-specific gene expression is more common than previously thought, reaching up to 50% of human genes. To identify genes displaying differential expression among alleles it is important for the understanding of several diseases, including the cancer. Identification of genes submitted to allelic-specific differential expression is hard, mostly due to the difficulty in evaluating the expression levels of each allele independently. In this work, we developed an in-silico approach, based on the integration of public data about the human genome, gene expression data (such as cDNAs, SNPs, SAGE and MPSS) and data on polymorphisms (SNPs). We developed a database of Single Nucleotide Polymorphisms (SNPs) associated to alternative SAGE (Serial Analysis of Gene Expression) and MPSS (Massively Parallel Signature Sequencing) tags. SAGE and MPSS are genome-wide techniques developed for analysis of gene expression. Both techniques rely on the production of short marker sequences (known as tags), adjacent to restriction sites closer to the poly-A tail of messenger RNAs. Such tags are sequenced in a large scale and tag counts are used to measure the relative abundance of their corresponding transcripts. The presence of SNPs in the restriction sites or in the tag sequences might generate allelic-specific tags for the same gene, which we call alternative tags. In this work, we used the database of SNPs and associated alternative tags to identify genes submitted to allelic-specific differential gene expression. Using this approach, we identified 812 genes showing allelic-specific differential gene expression. Previous studies have shown that, among the 812 candidates, five genes are targets for genomic imprinting. While this study was being performed, work done by other groups suggested other 73 genes in our candidates list to have different expression levels for alleles in heterozygous. Aiming to verify whether variations in the expression levels of alleles existed among our candidate genes, we submitted 29 genes for experimental validation. For 12 genes, we couldnt find heterozygous individuals, thus rendering it impossible to ascertain whether the supposed expression variation was true. Among the other 17 genes analyzed, three genes presented bi-allelic expression and 14 genes have shown clear differential expression among alleles, three of the last ones displaying strict mono-allelic expression. These results suggest that our approach may contribute significantly to the identification of genes with allelic-specific differential expression.

Plasmodium vivax é a espécie de malária humana de maior distribuição geográfica, com 35 milhões de casos por ano. No Brasil, é a espécie mais prevalente, sendo responsável por cerca de 70% dos casos de malária. Diferentemente do P. falciparum, o P. vivax apresenta hipnozoítas, formas que se mantêm em estágio dormente no fígado e que, após um período de tempo variável, por mecanismos ainda desconhecidos, causam novo ataque malárico denominado recaída. Para contribuir para um melhor conhecimento acerca das recaídas causadas por P. vivax, neste trabalho foram analisadas amostras pareadas referentes ao ataque primário e à recaída de 10 pacientes que se infectaram na Amazônia Brasileira. Através da amplificação de um segmento polimórfico do gene que codifica a Proteína de Superfície do Merozoíta 1 (PvMSP1), foi encontrado um índice de 40% de infecções mistas, presentes inclusive durante a recaída, indicando que a ativação de hipnozoítas não é clonal. Em análise mais detalhada deste segmento polimórfico, utilizando técnicas de clonagem e sequenciamento, foi possível verificar que a população de parasitas obtida durante o ataque primário é idêntica àquela que surge nas recaídas. O estudo da resposta IgG específica naturalmente adquirida contra a região C-terminal da PvMSP1, a mais imunogênica da molécula, demonstrou, durante a recaída, um aumento nos títulos acompanhado por uma maturação na afinidade destes anticorpos além de um predomínio de IgG1. / Plasmodium vivax is the most widely distributed human malarial parasite causing an estimated 35 million cases annually. In some parts of the world, including Brazil where it reaches almost 70% of malaria cases, this is the most prevalent species. Unlike P. falciparum, P. vivax has hypnozoites, hepatocyte dormant stages that cause clinical and parasitological relapses. Unfortunately, the molecular basis of relapses remain poorly understood. This work compared paired primary attack and relapse samples obtained from 10 infected patients from the brazilian Amazon Region using a polymorphic segment of the gene encoding the Merozoite Surface Protein 1 (PvMSP1) as a genetic marker. PCR, Southern blot and DNA sequence analysis demonstrated that the parasite population from the primary attack is identical to the one arising during relapses and that the activation of hypnozoites is not clonal; moreover, a large percentage (40%) of mixed infections, were detected. Studies on the naturally acquired human specific IgG response of these patients against the C-terminal region of the PvMSP1 molecule, the most immunogenic region, demonstrated an increase in the titers, affinity maturation and a predominance of the IgG1 subclass during the relapse.